Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells

Brain Research

Volumn 968, Issue 2, 2003, Pages 192-198

  Esposito, Pamela ^a   Basu, Subimal ^a   Letourneau, Richard ^a   Jacobson, Stanley ^a   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BBB; cAMP; CRF; Endothelial cells; Multiple sclerosis; Stress

Indexed keywords

ADENYLATE CYCLASE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; UROCORTIN;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CATTLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HORMONAL REGULATION; HORMONE ACTION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 0037432516     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02237-6     Document Type: Article

References (43)

1. Audus K.L., Borchardt R.T. Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann. NY Acad. Sci. 507:1987;9-18.
2. Belova I., Jonsson G. Blood-brain barrier permeability and immobilization stress. Acta Physiol. Scand. 116:1982;21-29.
3. Boertje S.R., Le Beau D., Williams C. Blockade of histamine-stimulated alterations in cerebrovascular permeability by the H2-receptor antagonist cimetidine. Neuropharmacology. 28:1989;749-752.
4. Chandler N., Jacobson S., Connolly R., Esposito P., Theoharides T.C. Acute stress shortens the time of onset of experimental allergic encephalomyelitis (EAE) in SJL/J mice. Brain, Behav. Immun. 16:2002;757-763.
5. Chen Y., Brunson K.L., Müller M.B., Cariaga W., Baram T.Z. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF1)-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 420:2000;305-323.
6. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New Engl. J. Med. 332:1995;1351-1362.
7. Clifton V.L., Read M.A., Leitch I.M., Giles W.B., Boura A.L.A., Robinson P.J., Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J. Clin. Endocrinol. Metab. 80:1995;2888-2893.
8. Cocchiara R., Bongiovanni A., Albeggiani G., Azzolina A., Geraci D. Evidence that brain mast cells can modulate neuroinflammatory responses by tumor necrosis factor-a production. Neuroreport. 9:1998;95-98.
9. De Vreis H.E., Kuiper J., de Boer A.G., Van Berkel T.J.C., Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49:1997;143-155.
10. 99Technetium-gluceptate extravasation in rat brain. Brain Res. Protocols. 8:2001;143-149.
11. Esposito P., Gheorghe D., Kandere K., Pang X., Conally R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood-brain barrier through activation of brain mast cells. Brain Res. 888:2001;117-127.
12. Esposito P., Chandler N., Kandere-Grzybowska K., Basu S., Jacobson S., Connolly R., Tutor D., Theoharides T.C. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303:2002;1061-1066.
13. Fleisher-Berkovich S., Danon A. Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts. Endocrinology. 136:1995;4068-4972.
14. Goodin D.S., Ebers G.C., Johnson K.P., Rodriguez M., Sibley W.A., Wolinsky J.S. The relationship of MS to physical trauma and psychological stress. Neurology. 52:1999;1737-1745.
15. Hanin I. The Gulf War, stress and a leaky blood-brain barrier. Nat. Med. 2:1996;1307-1308.
16. Hartung H.-P., Reiners K., Archelos J.J., Michels M., Seeldrayers P., Heidenreich F., Pflughaupt K.W., Toyka K.V. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging. Ann. Neurol. 38:1995;186-193.
17. Hendryk S., Jedrzejowska-Szypulka H., Josko J., Jarzab B., Dohler K.D. Influence of the corticotropin releasing hormone (CRH) on the brain-blood barrier permeability in cerebral ischemia in rats. J. Physiol. Pharmacol. 53:2002;85-94.
18. Jain V., Longo M., Ali M., Saade G.R., Chwalisz K., Garfield R.E. Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J. Soc. Gynecol. Invest. 7:2000;153-160.
19. Johansson B.B. The physiology of the blood-brain barrier. Adv. Exp. Med. Biol. 274:1990;25-39.
20. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:1991;421-423.
21. Kermode A.G., Thompson A.J., Tofts P., MacManus D.G., Kendall B.E., Kingsley D.P.E., Moseley I.F., Rudge P., McDonald W.I. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain. 113:1990;1477-1489.
22. Kim K.S., Wass C.A., Cross A.S., Opal S.M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 11:1992;293-298.
23. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1b in mediating NF-kB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J. Neurosci. 19:1999;10923-10930.
24. Lezoualc'h F., Engert S., Berning B., Behl C. Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB. Mol. Endocrinol. 14:2000;147-159.
25. Mayhan W.G. Leukocyte adherence contributes to disruption of the blood-brain barrier during activation of mast cells. Brain Res. 869:2000;112-120.
26. Mei-Tal V., Meyerowitz S., Engel G.L. The role of psychological process in a somatic disorder: multiple sclerosis. 1. The emotional setting of illness onset and exacerbation. Psychosom. Med. 32:1970;67-86.
27. A. Pisarchik, A. Slominski, Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variations and their differential expression, FASEB J. October 15, 2001 (published online).
28. Poliak S., Mor F., Conlon P., Wong T., Ling N., Rivier J., Vale W., Steinman L. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158:1997;5751-5756.
29. Robinson-White A., Beaven M.A. Presence of histamine and histamine-metabolizing enzyme in rat and guinea-pig microvascular endothelial cells. J. Pharmacol. Exp. Ther. 223:1982;440-445.
30. Rubin L.L., Hall D.E., Porter S., Barbu K., Cannon C., Horner H.C., Janatpour M., Liaw C.W., Manning K., Morales J., et al. A cell culture model of the blood-brain barrier. J. Cell Biol. 115:1991;1725-1735.
31. Sharma H.S., Cervos-Navarro J., Dey P.K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci. Res. 10:1991;211-221.
32. Sharma H.S., Westman J., Navarro J.C., Dey P.K., Nyberg F. Probable involvement of serotonin in the increased permeability of the blood-brain barrier by forced swimming. An experimental study using Evans blue and 131I-sodium tracers in the rat. Behav. Brain Res. 72:1995;189-196.
33. Simoncini T., Apa R., Reis F.M., Micelli F., Stomati M., Driul L., Lanzone A., Genazzani A.R., Petraglia F. Human umbilical vein endothelial cells: A new source and potential target for corticotropin-releasing factor. J. Clin. Endocrinol. Metab. 84:1999;2802-2806.
34. Skultetyova I., Tokarev D., Jezova D. Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats. Brain Res. Bull. 45:1998;175-178.
35. Sueki H., Stoudemayer T., Kligman A.M., Murphy G.F. Quantitative and ultrastructural analysis of inflammatory infiltrates in male pattern alopecia. Acta Dermatol. Venereol. 79:1999;347-350.
36. Sugimoto K., Kandere K., Kempuraj D., Letourneau L., Athanasiou A., Theoharides T.C. Human mast cell expression of corticotropin-releasing hormone (CRH) receptors and selective release of interleukin-6 (IL-6) by CRH may explain stress-induced atopic diseases. Pharmacologist. 44:2002;A241.
37. Theoharides T.C. Mast cells: the immune gate to the brain. Life Sci. 46:1990;607-617.
38. Theoharides T.C., Spanos C.P., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
39. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology. 139:1998;403-413.
40. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
41. Wolburg H., Neuhaus J., Kniesel U., Krauss B., Schmid E.M., Ocalan M., Farrell C., Risau W. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J. Cell Sci. 107:1994;1347-1357.
42. 2+ rather than of cAMP. Life Sci. 67:2000;2605-2613.
43. Zhuang X., Silverman A.-J., Silver R. Brain mast cell degranulation regulates blood-brain barrier. J. Neurobiol. 31:1996;393-403.